# Metabolism of Antituberculosis Drugs in HIV-Infected Persons With Tuberculosis

> **NCT00000950** · NA · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 50 (—)

## Conditions studied

- HIV Infections
- Tuberculosis

## Interventions

- **DRUG:** Ethambutol hydrochloride
- **DRUG:** Isoniazid
- **DRUG:** Pyrazinamide
- **DRUG:** Pyridoxine hydrochloride
- **DRUG:** Rifampin

## Key facts

- **NCT ID:** NCT00000950
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** 2002-05
- **Final completion:** —
- **Target enrollment:** 50 (—)
- **Last updated:** 2011-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000950

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000950, "Metabolism of Antituberculosis Drugs in HIV-Infected Persons With Tuberculosis". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT00000950. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*